Avita Medical Initiates European Trial Using ReCell in the Management of Chronic Lower Limb Ulcers

Marketwired
Avita Medical Initiates European Trial Using ReCell in the Management of Chronic Lower Limb Ulcers
Healing of chronic lower limb ulcers in one participating study center. 95% of ulcers achieved closure of 80% or better within 60 days following a single treatment with ReCell. Click here for high-resolution version
View Comments (0)